Emergence of BCR-ABL1 Chronic Myeloid Leukemia in a JAK2-V617F Polycythemia Vera
Journal of Hematology2020Vol. 9(1-2), pp. 23–29
Citations Over TimeTop 19% of 2020 papers
Abstract
Emergence of a new chronic myeloid neoplasm in the setting of a previous one, or their concomitant appearance seems to be a rare event, but plenty of cases have been reported. We describe the case of a patient with JAK2-V617F polycythemia vera, which looses JAK2 clone and develops overt BCR-ABL1 chronic myeloid leukemia after 6 years. Once treatment with tyrosine kinase inhibitors controls BCR-ABL1 clone, JAK2 clone arises again. In this report, we review the literature and discuss the clonal relationship of this event in light of the new molecular data.
Related Papers
- → JAK2Mutations in Polycythemia Vera — Molecular Mechanisms and Clinical Applications(2007)47 cited
- → Absence of CALR mutations in JAK2 -negative polycythemia(2016)16 cited
- → Chronic Lymphocytic Leukemia and Polycythemia Vera Concomitantly Diagnosed: Case Report(2017)
- → Faculty Opinions recommendation of Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.(2013)